Johnson & Johnson Increase (Decrease) in Accounts Payable and Accrued Liabilities
Johnson & Johnson (JNJ) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$956.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-23
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-28 was $2.96B, a 139.03% increase year-over-year.
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-29 was -$3.92B.
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-28 was $1.27B.
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-28 was $2.00B, a 11.79% decline year-over-year.
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.38B, a 46.64% increase from fiscal 2024.
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $1.62B, a 30.90% decline from fiscal 2023.
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $2.35B, a 113.66% increase from fiscal 2023.
- Johnson & Johnson increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.10B, a 54.94% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $2.96B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$956.00M 10-Q · filed 2026-07-23 | $310.00M derived: sum of 3 quarters · filed 2026-07-23 | $2.31B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-29 | -$3.92B 10-Q · filed 2026-04-22 | -$2.65B derived: sum of 2 quarters · filed 2026-04-22 | -$657.00M derived: sum of 3 quarters · filed 2026-04-22 | $583.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-28 | $1.27B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $3.26B derived: sum of 2 quarters · filed 2026-02-11 | $4.50B derived: sum of 3 quarters · filed 2026-07-23 | $2.38B 10-K · filed 2026-02-11 | ||||
| 2025-09-28 | $2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $3.24B derived: sum of 2 quarters · filed 2026-07-23 | $1.11B 10-Q · filed 2025-10-22 | $19.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-29 | $1.24B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$886.00M 10-Q · filed 2026-07-23 | -$1.98B derived: sum of 3 quarters · filed 2026-07-23 | $286.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-30 | -$2.13B 10-Q · filed 2026-04-22 | -$3.22B derived: sum of 2 quarters · filed 2026-04-22 | -$954.00M derived: sum of 3 quarters · filed 2026-04-22 | $1.98B derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-29 | -$1.09B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.17B derived: sum of 2 quarters · filed 2026-02-11 | $4.10B derived: sum of 3 quarters · filed 2026-02-11 | $1.62B 10-K · filed 2026-02-11 | ||||
| 2024-09-29 | $2.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $5.20B derived: sum of 2 quarters · filed 2025-10-22 | $2.71B 10-Q · filed 2025-10-22 | $4.39B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $2.93B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $449.00M 10-Q · filed 2025-07-24 | $2.13B derived: sum of 3 quarters · filed 2026-02-11 | $3.86B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | -$2.48B 10-Q · filed 2025-04-23 | -$801.00M derived: sum of 2 quarters · filed 2026-02-11 | $924.00M derived: sum of 3 quarters · filed 2026-02-11 | $2.44B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $1.68B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $3.41B derived: sum of 2 quarters · filed 2026-02-11 | $4.92B derived: sum of 3 quarters · filed 2026-02-11 | $2.35B 10-K · filed 2026-02-11 | ||||
| 2023-10-01 | $1.73B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-23 | $3.24B derived: sum of 2 quarters · filed 2024-10-23 | $664.00M 10-Q · filed 2024-10-23 | $1.62B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-07-02 | $1.51B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | -$1.06B 10-Q · filed 2024-07-25 | -$104.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.21B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-04-02 | -$2.57B 10-Q · filed 2024-05-01 | -$1.61B derived: sum of 2 quarters · filed 2025-02-13 | -$304.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.34B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-01-01 | $957.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $2.27B derived: sum of 2 quarters · filed 2025-02-13 | $3.92B derived: sum of 3 quarters · filed 2025-02-13 | $1.10B 10-K · filed 2025-02-13 | ||||
| 2022-10-02 | $1.31B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $2.96B derived: sum of 2 quarters · filed 2023-10-27 | $141.00M 10-Q · filed 2023-10-27 | $2.40B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-07-03 | $1.65B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | -$1.17B 10-Q · filed 2023-07-31 | $1.08B derived: sum of 3 quarters · filed 2024-02-16 | $5.32B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-04-03 | -$2.82B 10-Q · filed 2023-04-28 | -$562.00M derived: sum of 2 quarters · filed 2024-02-16 | $3.67B derived: sum of 3 quarters · filed 2024-02-16 | $1.96B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-01-02 | $2.25B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $6.49B derived: sum of 2 quarters · filed 2024-02-16 | $4.77B derived: sum of 3 quarters · filed 2024-02-16 | $2.44B 10-K · filed 2024-02-16 | ||||
| 2021-10-03 | $4.23B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $2.52B derived: sum of 2 quarters · filed 2022-10-27 | $182.00M 10-Q · filed 2022-10-27 | $5.44B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-07-04 | -$1.71B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | -$4.05B 10-Q · filed 2022-07-29 | $1.21B derived: sum of 3 quarters · filed 2023-02-16 | $3.41B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-04-04 | -$2.34B 10-Q · filed 2022-04-29 | $2.92B derived: sum of 2 quarters · filed 2023-02-16 | $5.12B derived: sum of 3 quarters · filed 2023-02-16 | $5.33B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-01-03 | $5.26B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $7.46B derived: sum of 2 quarters · filed 2023-02-16 | $7.66B derived: sum of 3 quarters · filed 2023-02-16 | $5.14B 10-K · filed 2023-02-16 | ||||
| 2020-09-27 | $2.20B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $2.40B derived: sum of 2 quarters · filed 2021-10-29 | -$119.00M 10-Q · filed 2021-10-29 | $1.67B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-28 | $204.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$2.32B 10-Q · filed 2021-07-29 | -$532.00M derived: sum of 3 quarters · filed 2022-02-17 | $2.19B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-29 | -$2.52B 10-Q · filed 2021-04-30 | -$736.00M derived: sum of 2 quarters · filed 2022-02-17 | $1.98B derived: sum of 3 quarters · filed 2022-02-17 | $3.37B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-29 | $1.79B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $4.50B derived: sum of 2 quarters · filed 2022-02-17 | $5.89B derived: sum of 3 quarters · filed 2022-02-17 | $4.06B 10-K · filed 2022-02-17 | ||||
| 2019-09-29 | $2.72B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $4.11B derived: sum of 2 quarters · filed 2020-10-23 | $2.27B 10-Q · filed 2020-10-23 | $5.49B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $1.39B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | -$444.00M 10-Q · filed 2020-07-24 | $2.78B derived: sum of 3 quarters · filed 2021-02-22 | $3.56B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | -$1.83B 10-Q · filed 2020-04-29 | $1.39B derived: sum of 2 quarters · filed 2021-02-22 | $2.17B derived: sum of 3 quarters · filed 2021-02-22 | $3.80B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-30 | $3.22B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $4.00B derived: sum of 2 quarters · filed 2021-02-22 | $5.64B derived: sum of 3 quarters · filed 2021-02-22 | $3.95B 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $780.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $2.42B derived: sum of 2 quarters · filed 2019-10-28 | $731.00M 10-Q · filed 2019-10-28 | $3.12B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-07-01 | $1.64B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | -$49.00M 10-Q · filed 2019-07-29 | $2.34B derived: sum of 3 quarters · filed 2020-02-18 | $3.88B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-04-01 | -$1.69B 10-Q · filed 2019-05-01 | $700.00M derived: sum of 2 quarters · filed 2020-02-18 | $2.24B derived: sum of 3 quarters · filed 2020-02-18 | $3.07B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $2.39B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $3.93B derived: sum of 2 quarters · filed 2020-02-18 | $4.75B derived: sum of 3 quarters · filed 2020-02-18 | $2.73B 10-K · filed 2020-02-18 | ||||
| 2017-10-01 | $1.54B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $2.37B derived: sum of 2 quarters · filed 2018-10-31 | $339.00M 10-Q · filed 2018-10-31 | $2.21B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-07-02 | $829.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$1.20B 10-Q · filed 2018-08-02 | $675.00M derived: sum of 3 quarters · filed 2019-02-20 | $502.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-04-02 | -$2.03B 10-Q · filed 2018-05-01 | -$154.00M derived: sum of 2 quarters · filed 2019-02-20 | -$327.00M derived: sum of 3 quarters · filed 2019-02-20 | $698.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-01-01 | $1.88B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.70B derived: sum of 2 quarters · filed 2019-02-20 | $2.73B derived: sum of 3 quarters · filed 2019-02-20 | $656.00M 10-K · filed 2019-02-20 | ||||
| 2016-10-02 | -$173.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $852.00M derived: sum of 2 quarters · filed 2017-11-02 | -$1.22B 10-Q · filed 2017-11-02 | $338.00M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-07-03 | $1.02B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$1.05B 10-Q · filed 2017-08-03 | $511.00M derived: sum of 3 quarters · filed 2018-02-21 | $1.17B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-04-03 | -$2.07B 10-Q · filed 2017-05-08 | -$2.33B 10-Q · filed 2016-05-10 | -$514.00M derived: sum of 2 quarters · filed 2018-02-21 | $146.00M derived: sum of 3 quarters · filed 2018-02-21 | $666.00M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-01-03 | $1.56B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $2.22B derived: sum of 2 quarters · filed 2018-02-21 | $2.74B derived: sum of 3 quarters · filed 2018-02-21 | $287.00M 10-K · filed 2018-02-21 | -$3.00M 10-K · filed 2016-02-24 | |||
| 2015-09-27 | $660.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.18B derived: sum of 2 quarters · filed 2016-11-04 | -$1.27B 10-Q · filed 2016-11-04 | -$1.56B 10-Q · filed 2015-10-30 | $750.00M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-28 | $520.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.93B 10-Q · filed 2016-08-04 | -$2.20B 10-Q · filed 2015-07-31 | $90.00M derived: sum of 3 quarters · filed 2017-02-27 | -$142.00M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-29 | -$2.45B 10-Q · filed 2016-05-10 | -$430.00M derived: sum of 2 quarters · filed 2017-02-27 | -$662.00M derived: sum of 3 quarters · filed 2017-02-27 | -$253.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-28 | $2.02B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.79B derived: sum of 2 quarters · filed 2017-02-27 | $2.20B derived: sum of 3 quarters · filed 2017-02-27 | $1.19B 10-K · filed 2017-02-27 | $955.00M 10-K · filed 2015-02-24 | |||
| 2014-09-28 | -$232.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $177.00M derived: sum of 2 quarters · filed 2015-10-30 | -$827.00M 10-Q · filed 2015-10-30 | $405.00M derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-06-29 | $409.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$595.00M 10-Q · filed 2015-07-31 | $637.00M derived: sum of 3 quarters · filed 2016-02-24 | $1.94B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-03-30 | -$1.00B 10-Q · filed 2015-05-01 | $228.00M derived: sum of 2 quarters · filed 2016-02-24 | $1.53B derived: sum of 3 quarters · filed 2016-02-24 | $2.28B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2013-12-29 | $1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $2.54B derived: sum of 2 quarters · filed 2016-02-24 | $3.28B derived: sum of 3 quarters · filed 2016-02-24 | $1.82B 10-K · filed 2016-02-24 | ||||
| 2013-09-29 | $1.30B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $2.05B derived: sum of 2 quarters · filed 2014-10-30 | $589.00M 10-Q · filed 2014-10-30 | $2.14B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $744.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$715.00M 10-Q · filed 2014-08-01 | $833.00M derived: sum of 3 quarters · filed 2015-02-24 | $1.15B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$1.46B 10-Q · filed 2014-05-02 | $89.00M derived: sum of 2 quarters · filed 2015-02-24 | $410.00M derived: sum of 3 quarters · filed 2015-02-24 | $2.64B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-30 | $1.55B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $1.87B derived: sum of 2 quarters · filed 2015-02-24 | $4.10B derived: sum of 3 quarters · filed 2015-02-24 | $2.77B 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $321.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $2.55B derived: sum of 2 quarters · filed 2013-11-04 | $1.22B 10-Q · filed 2013-11-04 | $1.81B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-07-01 | $2.23B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $899.00M 10-Q · filed 2013-08-01 | $1.49B derived: sum of 3 quarters · filed 2014-02-21 | $1.84B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-04-01 | -$1.33B 10-Q · filed 2013-05-03 | -$738.00M derived: sum of 2 quarters · filed 2014-02-21 | -$394.00M derived: sum of 3 quarters · filed 2014-02-21 | $289.00M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-01-01 | $593.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $937.00M derived: sum of 2 quarters · filed 2014-02-21 | $1.62B derived: sum of 3 quarters · filed 2014-02-21 | $493.00M 10-K · filed 2014-02-21 | ||||
| 2011-10-02 | $344.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.03B derived: sum of 2 quarters · filed 2012-11-09 | -$100.00M 10-Q · filed 2012-11-09 | $1.47B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-07-03 | $683.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$444.00M 10-Q · filed 2012-08-02 | $1.13B derived: sum of 3 quarters · filed 2013-02-22 | $1.29B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-04-03 | -$1.13B 10-Q · filed 2012-05-07 | $445.00M derived: sum of 2 quarters · filed 2013-02-22 | $612.00M derived: sum of 3 quarters · filed 2013-02-22 | $544.00M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-01-02 | $1.57B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $1.74B derived: sum of 2 quarters · filed 2013-02-22 | $1.67B derived: sum of 3 quarters · filed 2013-02-22 | $20.00M 10-K · filed 2013-02-22 | ||||
| 2010-10-03 | $167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $99.00M derived: sum of 2 quarters · filed 2011-11-08 | -$1.55B 10-Q · filed 2011-11-08 | -$229.00M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-07-04 | -$68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$1.72B 10-Q · filed 2011-08-09 | -$396.00M derived: sum of 3 quarters · filed 2012-02-23 | -$329.00M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-04-04 | -$1.65B 10-Q · filed 2011-05-10 | -$328.00M derived: sum of 2 quarters · filed 2012-02-23 | -$261.00M derived: sum of 3 quarters · filed 2012-02-23 | -$3.00M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-01-03 | $1.32B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $1.39B derived: sum of 2 quarters · filed 2012-02-23 | $1.65B derived: sum of 3 quarters · filed 2012-02-23 | -$507.00M 10-K · filed 2012-02-23 | ||||
| 2009-09-27 | $67.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | $325.00M derived: sum of 2 quarters · filed 2010-11-10 | -$1.83B 10-Q · filed 2010-11-10 | -$999.00M derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-28 | $258.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-11 | -$1.90B 10-Q · filed 2010-08-11 | -$1.07B derived: sum of 3 quarters · filed 2011-02-25 | -$1.01B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-03-29 | -$2.15B 10-Q · filed 2010-05-10 | -$1.32B derived: sum of 2 quarters · filed 2011-02-25 | -$1.27B derived: sum of 3 quarters · filed 2011-02-25 | |||||
| 2008-12-28 | $831.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $888.00M derived: sum of 2 quarters · filed 2011-02-25 | -$272.00M 10-K · filed 2011-02-25 | |||||
| 2008-09-28 | $57.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-04 | -$1.10B 10-Q · filed 2009-11-04 | ||||||
| 2008-06-29 | -$1.16B 10-Q · filed 2009-08-04 | |||||||
| 2007-12-30 | $2.64B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |